The metabolic clinical risk score as a new prognostic model for surgical decision-making in patients with colorectal liver metastases.

Auteurs : Duran Derijckere I, Levillain H, Bohlok A, Mathey C, Nezri J, Muteganya R, Trotta N, Lucidi V, Bouazza F, Germanova D, Van Simaeys G, Goldman S, Hendlisz A, Flamen P, Donckier V
Jaar : 2019
Journal : J Surg Oncol

Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer

Auteurs : Woff E, Hendlisz A, Ameye L, Garcia C, Kamoun T, Guiot T, Paesmans M, Flamen P
Jaar : 2019
Journal : J Nucl Med
Volume : 60
Pagina's : 178-184

90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer.

Auteurs : Levillain H, Duran Derijckere I, Marin G, Guiot T, Vouche M, Reynaert N, Hendlisz A, Vanderlinden B, Flamen P
Jaar : 2018
Journal : EJNMMI Res
Volume : 8
Pagina's : 60

The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.

Auteurs : Bohlok A, Hendlisz A, Bouazza F, Gomez Galdon M, Van de Stadt J, Moretti L, El Nakadi I, Liberale G
Jaar : 2018
Journal : Int J Colorectal Dis
Volume : 33(10)
Pagina's : 1383-1391

The unbearable lightness of therapeutic algorithms in colorectal liver metastasis.

Auteurs : Hendlisz A, Donckier V
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 260-261

Acute Pancreatitis Following Peptide Receptor Radionuclide Therapy: An Unusual Adverse Event.

Auteurs : Karfis I, Marin G, Machiels G, Hendlisz A, Flamen P
Jaar : 2018
Journal : Clin Nucl Med
Volume : 43(7)
Pagina's : e232-e233

Pseudoadjuvant chemotherapy in resectable metastatic colorectal cancer.

Auteurs : Polastro L, El Hachem G, Hendlisz A
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 269-275

The concept of oligometastases in colorectal cancer: from the clinical evidences to new therapeutic strategies.

Auteurs : Massaut E, Bohlok A, Lucidi V, Hendlisz A, Klastersky J, Donckier V
Jaar : 2018
Journal : Curr Opin Oncol
Volume : 30(4)
Pagina's : 262-268

Celyad's novel CAR T-cell therapy for solid malignancies.

Auteurs : Lonez C, Hendlisz A, Shaza L, Aftimos P, Vouche M, Donckier V, Machiels JH, Van den Eynde M, Canon JL, Carrasco J, Odunsi K, Sahebjam S, Rottey S, Braun N, Verma B, Gilham DE, Lehmann FF
Jaar : 2018
Journal : Curr Res Transl Med
Volume : 66(2)
Pagina's : 53-56

Circulating tumor DNA in early response assessment and monitoring of advanced colorectal cancer treated with a multi-kinase inhibitor.

Auteurs : Vandeputte C, Kehagias P, El Housni H, Ameye L, Laes JF, Desmedt C, Sotiriou C, Deleporte A, Puleo F, Geboes K, Delaunoit T, Demolin G, Peeters M, DHondt L, Janssens J, Carrasco J, Marechal R, Gomez Galdon M, Heimann P, Paesmans M, Flamen P, Hendlisz A
Jaar : 2018
Journal : Oncotarget
Volume : 9
Pagina's : 17756-17769

Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.

Auteurs : Lemaire M, Lucidi V, Bouazza F, Katsanos G, Vanderlinden B, Levillain H, Delatte P, Garcia CA, Vouche M, Gomez Galdon M, Demetter P, Deleporte A, Hendlisz A, Flamen P, Donckier V
Jaar : 2018
Journal : HPB (Oxford)
Volume : 20(7)
Pagina's : 641-648

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.

Auteurs : Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, van Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA, Ledeine JM, Cao ZA, Kamble S, Kopetz S, André T
Jaar : 2018
Journal : J Clin Oncol
Volume : 36(8)
Pagina's : 773-779

Sequential tumor-directed and lobar radioembolization before major hepatectomy for hepatocellular carcinoma.

Auteurs : Vouche M, Degrez T, Bouazza F, Delatte P, Gomez Galdon M, Hendlisz A, Flamen P, Donckier V
Jaar : 2017
Journal : World J Hepatol
Volume : 9
Pagina's : 1372-1377

The meaningness of colon cancer sidedness.

Auteurs : Hendlisz A
Jaar : 2017
Journal : Curr Opin Oncol
Volume : 29
Pagina's : 286-287

Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: A real standard?

Auteurs : Veereman G, Vlayen J, Robays J, Fairon N, Stordeur S, Rolfo C, Bielen D, Bols A, Demetter P, Dhoore A, Haustermans K, Hendlisz A, Lemmers A, Leonard D, Penninckx F, van Cutsem E, Peeters M
Jaar : 2017
Journal : Crit Rev Oncol Hematol
Volume : 114
Pagina's : 43-52

Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.

Auteurs : Lonez C, Verma B, Hendlisz A, Aftimos P, Awada A, Van Den Neste E, Catala G, Machiels JH, Piette F, Brayer JB, Sallman DA, Kerre T, Odunsi K, Davila ML, Gilham DE, Lehmann FF
Jaar : 2017
Journal : BMJ Open
Volume : 7(11)
Pagina's : e017075

Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.

Auteurs : Liberale G, Lecocq C, Garcia C, Muylle K, Covas A, Deleporte A, Hendlisz A, Bouazza F, El Nakadi I, Flamen P
Jaar : 2017
Journal : Anticancer Res
Volume : 37
Pagina's : 929-934

Dyspnea and cardia cancer, an unusual etiology.

Auteurs : Speybrouck S, Claeys L, Hendlisz A, Meert AP
Jaar : 2017
Journal : Rev Med Brux
Volume : 38
Pagina's : 162-168

Tackling immunomonitoring in gastrointestinal cancer.

Auteurs : Anciaux M, Vandeputte C, Hendlisz A
Jaar : 2017
Journal : Curr Opin Oncol
Volume : 29
Pagina's : 296-305

Do the Guidelines in Oncology Need to Evolve?

Auteurs : Awada A, Awada G, Hendlisz A
Jaar : 2016
Journal : Eur Med J
Volume : -
Pagina's : 15